Thomas Wilder

Thomas Wilder

Director/Board Member at PENUMBRA, INC.

Net worth: 1 M $ as of 2026-05-30

62 year
Health Technology
Consumer Services
Finance

Profile

Thomas C.
Wilder
is Chief Executive Officer at VS3 Medical, Inc. since 2024.
Independent Director at Penumbra, Inc. since 2017.
Independent Director at Neuros Medical, Inc. since 2023.
Senior Advisor at CBC Group (Singapore) Pte.
Ltd. since 2021.
Advisor at Vensana Capital Management LLC since 2019.
Formerly President & Chief Executive Officer at Micro Therapeutics, Inc. from 2002 to 2006.
President & Chief Executive Officer at PhotoThera, Inc. from 2006 to 2009.
President, Chief Executive Officer & Director at Sequent Medical, Inc. from 2010 to 2016.
Independent Director at Endologix LLC from 2010 to 2020.
Director at Benvenue Medical, Inc. from 2012 to 2017.
VP & GM-Endovascular Stent Grafts Division at Medtronic, Inc. from 1991 to 2002.
President at ev3, Inc. Vice President-Finance & Information Technology at Medtronic Vascular, Inc. Education includes an undergraduate degree from Stanford University in 1986 and an MBA from Kellogg School of Management in 1991.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 4,653 ( 0.01% ) 1 M $ 2026-05-30

Thomas Wilder active positions

CompaniesPositionStart
PENUMBRA, INC. Director/Board Member 2017-01-12
Director/Board Member 2017-08-27
Consultant / Advisor 2019-09-30
Consultant / Advisor 2021-06-30
Chief Executive Officer 2024-05-31

Former positions of Thomas Wilder

CompaniesPositionEnd
ENDOLOGIX, INC. Director/Board Member 2020-09-30
Director/Board Member 2017-03-31
Chief Executive Officer 2016-06-30
Chief Executive Officer 2009-04-29
░░░░ ░░░░ ░░░░░░░░░ -
See the detail of Thomas Wilder's experience

Training of Thomas Wilder

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Finance

Health Services